Wegovy® for weight loss prescription online

Obesity is a chronic health issue that requires long-term management and is associated with severe health complications, including heart disease, diabetes, sleep apnea, asthma, hormonal concerns for women such as PCOS, arthritis, and certain types of cancer. Losing five to ten percent of body weight can bring impactful health benefits, such as:

• Reduced risk of heart disease

• Improved energy

• Improved blood pressure, blood sugar, and cholesterol levels

On June 4, 2021, the U.S. Food and Drug Administration (FDA) approved Wegovy^® for adults who suffer from obesity or are overweight. This is the first drug for chronic weight management that has been approved since 2014.

Combined with a reduced-calorie meal plan and increased physical activity, Wegovy^® can be highly effective in helping patients lose weight.

Dedicated to providing individualized solutions, we recognize Wegovy®  as an outstanding choice; however, we aim to highlight alternatives for patients seeking the most suitable treatment for weight management. Our physicians may recommend or prescribe other GLP-1 options depending on availability and individual preferences. Explore these choices:

• Zepbound^® (tirzepatide): A breakthrough in weight management, this dual-action GLP-1 and GIP receptor agonist not only aids in regulating blood sugar levels but also presents a promising avenue for effective weight loss.

Other medications our doctors may prescribe for weight loss include:

• Xenical^® (orlistat): This medication blocks dietary fat breakdown and absorption by the body.

• Contrave^® (naltrexone/bupropion): This is a once-daily tablet that promotes weight loss by helping promote feelings of fullness.

Now, Wegovy^® isn't just for weight loss; it also can protect against life-threatening cardiovascular events. Recently approved for cardiovascular disease management by the FDA in March 2024, Wegovy^® is the first weight loss medication to offer this dual benefit.  Heart disease, heart attacks, and strokes are all-too-common risks associated with obesity and being overweight. This FDA-approved medication not only helps you shed excess weight but also can significantly reduce your risk of these potentially deadly cardiovascular events.⁴

In a rigorous trial involving over 17,600 participants, Wegovy^® significantly reduced the risk of major adverse cardiovascular events, including cardiovascular death, heart attack, and stroke.⁴  Other medications prescribed to lower the risk of life-threatening cardiovascular events include: 

• Statins such as Zocor (simvastatin), Lipitor (atorvastatin), and rosuvastatin (Crestor), which lower cholesterol levels 

• ACE inhibitors like Capoten (captopril), Altace (ramipril), Lotensin (benazepril), Accupril (quinapril), Lotrel (amlodipine & benazepril), and Vasotec (enalapril), which help relax blood vessels and lower blood pressure 

Consult with one of our doctors to learn about the best option for your cardiovascular health. 

Although Wegovy^® for weight loss has been proven safe and effective and was approved by the FDA, there are still unknown things, such as drug interactions. There have not yet been clinical trials testing Wegovy^® in combination with: 

• Insulin

• Prescription drugs

• Over-the-counter drugs

• Other products intended for weight loss

• Herbal weight loss products or other supplements

With Wegovy^®, there may be an increased risk for low blood sugar, especially when combined with the above.

Because drug and insulin interactions with Wegovy^® have not yet been studied, talking to your weight loss doctor is vital. You must disclose any personal or family history of medical conditions and all the medicines you take, including any over-the-counter medications, such as daily vitamins or herbal supplements, as they could affect the efficacy or safety of Wegovy^®.

Wegovy® ranges in price at different pharmacies from $1300-1500.  Unfortunately, there is no generic lower-cost version.

Most insurance plans require extra paperwork that we complete, called prior authorization, before they will consider covering the cost of branded weight loss medications.

If you're paying out of pocket, Wegovy® costs $499 per month (28-day supply) when filled through NovoCare® Pharmacy.

You may be eligible if you don’t have insurance or if your commercial insurance doesn’t cover Wegovy® and you’re paying cash.⁴

No, Wegovy® from NovoCare® is the same FDA-approved medication and comes in the same convenient autoinjector pen. The main difference is that NovoCare® offers a lower cash-pay option for eligible patients.

Although Wegovy® is the same chemical as Ozempic®, semaglutide, the main differences between Wegovy® and Ozempic® are their intended consumer and the slight differences in dosing. Wegovy® was created for and can be used by anyone who is overweight and has health concerns, while Ozempic® is FDA-approved only for patients with type 2 diabetes.

That being said, they have a lot in common. Novo Nordisk manufactures them both with the same active ingredient, semaglutide. However, the amount of semaglutide differs, with Wegovy’s final amount of semaglutide being 2.4 mg and Ozempic® having four dosing options: 0.25 mg, 0.5 mg, 1 mg, and 2 mg.